THE TMPRSS2:ERG REARRANGEMENT, ERG EXPRESSION, AND PROSTATE CANCER OUTCOMES: A COHORT STUDY AND META-ANALYSIS

BACKGROUND: Whether the genomic rearrangement TMPRSS2:ERG has prognostic value in prostate cancer is unclear. METHODS: Among men with prostate cancer in the prospective Physicians’ Health and Health Professionals Follow-Up Studies, we identified rearrangement status by immunohistochemical assessment...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pettersson, Andreas, Graff, Rebecca E., Bauer, Scott R., Pitt, Michael, Lis, Rosina T., Stack, Edward C., Martin, Neil E., Kunz, Lauren, Penney, Kathryn L., Ligon, Azra H., Suppan, Catherine, Flavin, Richard, Sesso, Howard D., Rider, Jennifer R., Sweeney, Christopher, Stampfer, Meir, Fiorentino, Michelangelo, Kantoff, Philip W., Sanda, Martin, Giovannucci, Edward, Ding, Eric L., Loda, Massimo, Mucci, Lorelei A.
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671609/
https://ncbi.nlm.nih.gov/pubmed/22736790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-12-0042
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares